News & Articles
Selected Filters:
African trial of novel HIV vaccine candidate starts
Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic
Researchers develop a promising new therapy to tackle metabolic liver disease, NASH
Dr. Erik Tillman shares his virtual company’s quest to find an effective new life-changing treatment for non-alcoholic steatohepatitis
ERS Genomics and Japan SLC sign CRISPR/Cas9 license agreement
Nobel prize winning CRISPR technology to be applied in development of genetically engineered animal models
Sherlock Biosciences announces initial results of automation study with NorDx Laboratories on CRISPR-based test for SARS-CoV-2
Leading clinical laboratory runs first-ever successful automation of a CRISPR test for high-throughput, using Sherlock’s SARS-CoV-2 process
Cell couriers deliver clue to cancer metastasis
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Longer interval between Pfizer vaccine doses boosts immunity
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
High blood sugar levels ‘reprogramme’ stem cells
Findings explain higher risk of heart attack in people with diabetes, even after treatment
Seegene introduces new SARS-CoV-2 variants detection test
The multiplex PCR test is capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases
Thermo Fisher Scientific expands hematology oncology NGS portfolio
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Taking a step toward discovering the cause of joint disease
Study finds switches near GDF5 gene linked to knee osteoarthritis, hip dysplasia
New insights into reproductive dysfunction with advanced spatial genomics
Dr. Lique Coolen and Dr. Aleisha Moore, Kent State University, present their latest research into the mechanisms underlying spinal cord injury and neuroendocrine dysfunction
A year of clinical research change, challenge, and champions: Your questions answered
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
Roche’s Actemra/RoActemra receives FDA EUA for the treatment of COVID-19
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
LGC’s ultra-high throughput Nexar™ technology provides significant PCR testing capacity at Rosalind Franklin Laboratory
LGC has been working with NHS Test and Trace to support the UK's response to the pandemic
Ortho Clinical Diagnostics’ quantitative COVID-19 IgG antibody test first to receive FDA EUA
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies
Highlights from the Virtual Clinical Science Summit 2021
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Univercells Technologies and VectorBuilder announce strategic partnership for optimized custom viral vector production
Univercells Technologies will work with VectorBuilder to develop and optimize NevoLine Upstream platform and scale-X bioreactors for the production of custom viral vectors
Expanded gene therapy portfolio supports more efficient adeno-associated viral manufacturing
The new media panel, gene kit and advanced resins help reduce manufacturing costs while increasing the viability of gene therapies